Tag: (NASDAQ:PHAS)

April 14, 2019

5 Top Weekly NASDAQ Biotech Stocks: PhaseBio Gets Breakthrough Therapy Designation

Vital Therapies, Precipio, Chimerix, ContraFect and PhaseBio Pharmaceuticals were last week's top gainers.
April 9, 2019

PhaseBio Announces Global License of PB1023 to Treat Sarcopenia-Related Diseases to ImmunoForge

PhaseBio Pharmaceuticals (NASDAQ:PHAS) has announced it has licensed the global rights of PB1023 to ImmunoForge. PB1023 is a recombinant GLP-1...
March 31, 2019

5 Top Weekly NASDAQ Biotech Stocks: Index Rebounds

Aveo Pharmaceuticals, Curis, Phasebio Pharmaceuticals, Arcturus Therapeutics and Krystal Biotech were last week's top gainers.
December 16, 2018

5 Top Weekly NASDAQ Biotech Stocks: Innovate Leads the Pack

Innovate Biopharmaceuticals, Aridis Pharmaceuticals, Imprimis Pharmaceuticals, Achaogen and SynthoRx were last week's top gainers.